"Treating Lung Cancer With Immunotherapy - How These Groundbreaking Drugs Work"
Despite the prevalence of lung cancer, it’s still one of the most misunderstood conditions, much of which is due to the stigmas associated with lung cancer. Because of these stigmas, people struggling with lung cancer may have fewer resources available to them, which may affect their ability to understand the latest treatment options. “Many patients don’t have a lot of information about lung cancer,” said Jorge Gomez, MD, a lung oncologist at The Mount Sinai Hospital. “Some of them haven’t heard about the newer therapies that can prolong life, can improve quality of life, and have had a significant impact in the treatment of lung cancer.” Dr. Gomez said, “Immunotherapies are newer therapies that are less toxic than chemotherapy and don’t attack the cancer directly like chemotherapy or targeted therapies,” said Dr. Gomez. “These drugs have at times been proven to be better than chemotherapy and are now approved in almost every scenario in lung cancer.”
- Jorge E. Gomez, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Lung Oncologist, The Mount Sinai Hospital
Additional coverage:
https://www.healthination.com/health/caregiver-tips-lung-cancer
https://www.healthination.com/health/advanced-lung-cancer-diagnosis
https://www.healthination.com/health/lung-cancer-treatment-nutrition
https://www.healthination.com/health/coping-with-lung-cancer-stigma